[go: up one dir, main page]

NO884835D0 - PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TETRAHYDRO-FURO- AND TIENO (2,3.-C) PYRIDINES. - Google Patents

PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TETRAHYDRO-FURO- AND TIENO (2,3.-C) PYRIDINES.

Info

Publication number
NO884835D0
NO884835D0 NO884835A NO884835A NO884835D0 NO 884835 D0 NO884835 D0 NO 884835D0 NO 884835 A NO884835 A NO 884835A NO 884835 A NO884835 A NO 884835A NO 884835 D0 NO884835 D0 NO 884835D0
Authority
NO
Norway
Prior art keywords
tieno
furo
pyridines
procedure
preparation
Prior art date
Application number
NO884835A
Other languages
Norwegian (no)
Other versions
NO884835L (en
Inventor
Albrecht Harreus
Karl-Heinz Weber
Werner Stransky
Gerhard Walther
Franz Josef Kuhn
Guenter Schingnitz
Helmut Ensinger
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO884835D0 publication Critical patent/NO884835D0/en
Publication of NO884835L publication Critical patent/NO884835L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO88884835A 1987-10-29 1988-10-28 PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TETRAHYDRO-FURO-AND-TIENO (2,3.-C) PYRIDINES. NO884835L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873736664 DE3736664A1 (en) 1987-10-29 1987-10-29 TETRAHYDRO-FURO- AND -THIENO (2,3-C) PYRIDINE, THEIR USE AS A MEDICAMENT AND METHOD FOR THE PRODUCTION THEREOF

Publications (2)

Publication Number Publication Date
NO884835D0 true NO884835D0 (en) 1988-10-28
NO884835L NO884835L (en) 1989-05-02

Family

ID=6339349

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88884835A NO884835L (en) 1987-10-29 1988-10-28 PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TETRAHYDRO-FURO-AND-TIENO (2,3.-C) PYRIDINES.

Country Status (17)

Country Link
EP (1) EP0314154A3 (en)
JP (1) JPH01157983A (en)
KR (1) KR890006650A (en)
AU (1) AU2443588A (en)
CS (1) CS273193B2 (en)
DD (1) DD283395A5 (en)
DE (1) DE3736664A1 (en)
DK (1) DK603588A (en)
FI (1) FI884947A (en)
HU (1) HU201553B (en)
IL (1) IL88184A0 (en)
NO (1) NO884835L (en)
PL (1) PL275555A1 (en)
PT (1) PT88899B (en)
SU (1) SU1657064A3 (en)
YU (1) YU201288A (en)
ZA (1) ZA888089B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (en) * 1987-02-17 1992-01-24 Sanofi Sa ALPHA SALTS- (TETRAHYDRO-4,5,6,7 THIENO (3,2-C) PYRIDYL-5) (2-CHLORO-PHENYL) -THETHYL ACETATE DEXTROGYRE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
US5272148A (en) * 1992-09-09 1993-12-21 Hoechst-Roussel Pharmaceuticals Incorporated Heteroarenylpiperazines
US8914114B2 (en) 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
CA2476896A1 (en) * 2002-02-26 2003-09-04 North Shore-Long Island Jewish Research Institute Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
EP1734941A2 (en) 2004-03-25 2006-12-27 The Feinstein Institute for Medical Research Neural tourniquet
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
EP1833559B1 (en) 2004-12-27 2010-11-24 The Feinstein Institute for Medical Research Treating inflammatory disorders by electrical vagus nerve stimulation
US8391970B2 (en) 2007-08-27 2013-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
US9211409B2 (en) 2008-03-31 2015-12-15 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of T-cell activity
CN102215909B (en) 2008-11-18 2014-09-10 赛博恩特医疗器械公司 Devices and methods for optimizing electrode placement for anti-inflamatory stimulation
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US8612002B2 (en) 2009-12-23 2013-12-17 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
US8996116B2 (en) 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
CN102573986B (en) 2009-06-09 2016-01-20 赛博恩特医疗器械公司 For the nerve cuff with bag portion without wire stimulator
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
US11051744B2 (en) 2009-11-17 2021-07-06 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
US12172017B2 (en) 2011-05-09 2024-12-24 Setpoint Medical Corporation Vagus nerve stimulation to treat neurodegenerative disorders
WO2012154865A2 (en) 2011-05-09 2012-11-15 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
WO2016126807A1 (en) 2015-02-03 2016-08-11 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
US10695569B2 (en) 2016-01-20 2020-06-30 Setpoint Medical Corporation Control of vagal stimulation
WO2017127758A1 (en) 2016-01-20 2017-07-27 Setpoint Medical Corporation Implantable microstimulators and inductive charging systems
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
US11173307B2 (en) 2017-08-14 2021-11-16 Setpoint Medical Corporation Vagus nerve stimulation pre-screening test
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
KR20230012585A (en) 2020-05-21 2023-01-26 더 파인스타인 인스티튜츠 포 메디칼 리서치 Systems and methods for vagus nerve stimulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2315274A1 (en) * 1975-06-27 1977-01-21 Parcor NEW DERIVATIVES OF THIENO (2,3-C) PYRIDINE, THEIR PREPARATION AND THEIR APPLICATIONS
FR2317303A1 (en) * 1975-07-09 1977-02-04 Parcor PROCESS FOR PREPARING TETRAHYDROTHIENO (3,2-C) AND (2,3-C) PYRIDINE DERIVATIVES

Also Published As

Publication number Publication date
AU2443588A (en) 1989-07-13
EP0314154A3 (en) 1990-12-05
HUT50824A (en) 1990-03-28
CS712688A2 (en) 1990-06-13
JPH01157983A (en) 1989-06-21
NO884835L (en) 1989-05-02
ZA888089B (en) 1990-07-25
HU201553B (en) 1990-11-28
PL275555A1 (en) 1989-05-02
CS273193B2 (en) 1991-03-12
DK603588D0 (en) 1988-10-28
PT88899B (en) 1993-01-29
DD283395A5 (en) 1990-10-10
YU201288A (en) 1990-08-31
DE3736664A1 (en) 1989-05-11
FI884947A0 (en) 1988-10-27
SU1657064A3 (en) 1991-06-15
DK603588A (en) 1989-04-30
IL88184A0 (en) 1989-06-30
FI884947A (en) 1989-04-30
EP0314154A2 (en) 1989-05-03
KR890006650A (en) 1989-06-15

Similar Documents

Publication Publication Date Title
NO884835D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TETRAHYDRO-FURO- AND TIENO (2,3.-C) PYRIDINES.
NO884154D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PREPARATIONS.
NO883974D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TETRAHYDRO-HYDROXYPYRANON DERIVATIVES.
NO880182L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,2-DIHYDRO-3H-INDAZOL-3-ON DERIVATIVES.
NO166367C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TIENO-1,4-DIAZEPINES.
NO166281C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE 1,1-DISUBSTITUTED CYCLOPROPANDER DERIVATIVES.
NO163619C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TETRAHYDRO-2-HETEROCYCLOYLKYLPYRIDO (4,3) INDOLES.
NO169963C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE, SUBSTITUTED 3,4-DIHYDRO-2H-BENZOPYRANES
FI871087A0 (en) Process for the preparation of therapeutically active 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo / oxo-5-pyrimidinecarboxylic acid derivatives
NO166326C (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3,7-SUBSTITUTED-8-OXO-5-THIA-1-AZABICYCLO- (4,2,0) OCT-2-EN-2-CARBOXYLATER.
NO167668C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE EPIPODOPHYLLOTOXING LUCOSIDE-4'-ACYL DERIVATIVES.
NO881768L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3-DIOXANES.
NO862390D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,4-DIHYDROPYRIDINE DERIVATIVES.
NO165542C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-ARYL-2,4-DIALKYL-3H-1,2,4-TRIAZOL-3-THIONER.
NO854277L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 6-PHENETYLAMINOALKYL-7-HYDROXY-FURO- (3,4-C) -PYRIDINE DERIVATIVES.
NO865148D0 (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE, SUBSTITUTED BENZAMIDES.
NO166642C (en) ANAOLOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3-ARYL-5-ALKYLTHIO-4H-1,2,4-TRIAZOLES.
NO163777C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DIOXINO (4,5-C) -PYRIDINE DERIVATIVES.
NO882281D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRAZINAMIDES.
NO880409D0 (en) PROCEDURE FOR THE PREPARATION OF 14.15 SUBSTITUTED LANOSTEROLS.
NO164973C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE GEM-DIHALO- AND TETRAHALO-1,2-DIAMINO-4,9, -DIAZA-DODECANES.
NO852563L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDINE DERIVATIVES.
NO883959L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PHENOLESTERS.
NO882282L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRAZINAMIDES.
NO882201D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDINE DERIVATIVES.